Seguimiento de los pacientes con diabetes tipo 2 durante la pandemia por COVID-19un estudio multicéntrico en Atención Primaria (Pag.-e 102075)

  1. Francisco Javier Cuevas Fernández 1
  2. O.T. Gómez López 1
  3. M. Dorta Espiñeira 1
  4. S. Farrais Villalba 1
  5. A. Cabrera de León 1
  6. Armando Aguirre Jaime 1
  1. 1 Universidad de La Laguna, Santa Cruz de Tenerife, España
Journal:
Semergen: revista española de medicina de familia

ISSN: 1138-3593

Year of publication: 2023

Issue: 8

Pages: 6-6

Type: Article

DOI: 10.1016/J.SEMERG.2023.102075 DIALNET GOOGLE SCHOLAR

More publications in: Semergen: revista española de medicina de familia

Abstract

Background The COVID-19 pandemic meant measures had to be taken that implied the neglect of patients with type 2 diabetes (T2D). Objectives to explore the impact of care discontinuity on patients with T2D in Primary Care (PC) centres, who did not have a specific action protocol for them, during 2020 and 2021. Design Multicenter retrospective observational study. Participants Patients with T2D in Tenerife, Canary Islands, Spain. Main Measurements Sex and age, follow-up variables of atherosclerotic vascular disease detection and control programme (pEVA), compliance with the control objectives and visits to the family practitioner and community nurse were extracted from their medical records. Results 3,543 participants took part in the study, 1,772 (50%) women, 2,204 (62%) of whom were older than 65 years of age. The vast majority of registered activities and control objectives decreased in 2020, recovering in 2021 without reaching 2019 levels. In 2020, telephone consultations increased and in-person consultations decreased, a trend that remained unchanged in 2021 for telephone consultations. Women and those over 65 years of age presented higher frequentation, more activity records and achievement of control objectives in most of the parameters. Conclusions The pandemic caused an overload in the PCs that affected the care of patients with T2D, which has not returned to pre-pandemic levels. Young men are the target for prioritization of this care. Anti-pandemic measures have led to an increase in telephone consultations, a resource that should be strengthened.

€ View funding

Funding information

Funders

Bibliographic References

  • D. Cucinotta, M. Vanelli WHO declares COVID-19 a pandemic Acta Biomed., 91 (2020), pp. 157-160 View in ScopusGoogle Scholar
  • M.J. Carr, A.K. Wright, L. Leelarathna, H. Thabit, N. Milne, N. Kanumill, et al. Impact of COVID-19 restrictions on diabetes health checks and prescribing for people with type 2 diabetes: A UK-wide cohort study involving 618161 people in primary care BMJ Qual Saf., 31 (2022), pp. 503-514, 10.1136/bmjqs-2021-013613 Epub 2021 Oct 12 View article View in ScopusGoogle Scholar
  • J. Jug, I. Peček, S. Bukvić, M. Petrovcic, F. Bosnic, A. Rukavuna, et al. Continuity of care in patients with type 2 diabetes in Croatian primary care setting during COVID-19 pandemic: A retrospective observational study Prim Care Diabetes., 16 (2022), pp. 768-774, 10.1016/j.pcd.2022.09.010 Epub 2022 Sep 28 View PDFView articleView in ScopusGoogle Scholar
  • A.D. Misra-Hebert, B. Hu, K.M. Pantalone, E.R. Pfoh Primary care health care use for patients with type 2 diabetes during the COVID-19 pandemic Diabetes Care., 44 (2021), pp. e173-e174, 10.2337/dc21-0853 View PDF This article is free to access. View in ScopusGoogle Scholar
  • T. Coll Benejam, J. Palacio Lapuente, R. Añel Rodríguez, M. Gens Barbera, J.J. Jurado Balbuena, A. Perelló Bratescu Primary care organization in pandemic times Aten Primaria., 53 (Suppl 1) (2021), p. 102209, 10.1016/j.aprim.2021.102209 View PDFView articleView in ScopusGoogle Scholar
  • B. Li, J. Yang, F. Zhao, L. Zhi, X. Wang, L. Liu, et al. Prevalen-ce and impact of cardiovascular metabolic diseases on COVID-19 in China Clin Res Cardiol., 109 (2020), pp. 531-538 View PDF This article is free to access. CrossRefView in ScopusGoogle Scholar
  • A. Misra, Z. Bloomgarden Diabetes during the COVID-19 pandemic: A global call to reconnect with patients and emphasize lifestyle changes and optimize glycemic and blood pressure control J Diabetes., 12 (2020), pp. 556-557, 10.1111/1753-0407.13048 View PDF This article is free to access. View in ScopusGoogle Scholar
  • S.R. Bornstein, F. Rubino, K. Khunti, G. Mingone, D. Hopkins, A.L. Birkenfeld, et al. Practical recommendations for the management of diabetes in patients with COVID-1 Lancet Diabetes Endocrinol., 8 (2020), pp. 546-550, 10.1016/S2213-8587(20)30152-2 Epub 2020 Apr 23 View PDFView articleView in ScopusGoogle Scholar
  • A.K. Singh, K. Khunti COVID-19 and diabetes Annu Rev Med., 73 (2022), pp. 129-147, 10.1146/annurev-med-042220-011857 Epub 2021 Aug 11 View article View in ScopusGoogle Scholar
  • J.M. Dennis, B.A. Mateen, R. Sonabend, N.J. Thomas, K.A. Patel, A.T. Hattersley, et al. Type 2 diabetes and COVID-19-related mortality in the critical care setting: A national cohort study in England Diabetes Care., 44 (2021), pp. 50-57, 10.2337/dc20-1444 Epub 2020 Oct 23 View PDF This article is free to access. View in ScopusGoogle Scholar
  • R. Odeh, L. Gharaibeh, A. Daher, S. Kussad, A. Alassaf Caring for a child with type 1 diabetes during COVID-19 lockdown in a developing country: Challenges and parents’ perspectives on the use of telemedicine Diabetes Res Clin Pract., 168 (2020), p. 108393, 10.1016/j.diabres.2020.108393 View PDFView articleView in ScopusGoogle Scholar
  • R. Rodriguez Escobedo, C. Alonso Felgueroso, G. Martinez Tames, S. Sánchez Ragnarsson, E.L. Menéndez Torres Evaluation of the consequences of the COVID-19 lockdown on glycemic control in type 1 diabetes Endocrinol Diabetes Nutr (Engl Ed). (2021), 10.1016/j.endien.2022.03.002 S2530-0164(21)00071-9. View PDF Your institution provides access to this article. Google Scholar
  • O. Psoma, E. Papachristoforou, A. Kountouri, K. Balampanos, A. Stergiou, V. Lambadiari, et al. Effect of COVID-19-associated lockdown on the metabolic control of patients with type 2 diabetes J Diabetes Complications., 34 (2020), p. 107756, 10.1016/j.jdiacomp.2020.107756 View PDFView articleView in ScopusGoogle Scholar
  • H.C. Felix, J.A. Andersen, D.E. Willis, J.R. Malhis, J.P. Selig, P.A. McElfish Control of type 2 diabetes mellitus during the COVID-19 pandemic Prim Care Diabetes. (2021), 10.1016/j.pcd.2021.06.012 S1751-9918(21)00116-9. View PDF Your institution provides access to this article. Google Scholar
  • P. Falcetta, M. Aragona, A. Ciccarone, A. Bertolotto, F. Campi, A. Copelli, et al. Impact of COVID-19 lockdown on glucose control of elderly people with type 2 diabetes in Italy Diabetes Res Clin Pract., 174 (2021), p. 108750, 10.1016/j.diabres.2021.108750 View PDFView articleView in ScopusGoogle Scholar
  • S. Karatas, T. Yesim, S. Beysel Impact of lockdown COVID-19 on metabolic control in type 2 diabetes mellitus and healthy people Prim Care Diabetes., 15 (2021), pp. 424-427, 10.1016/j.pcd.2021.01.003 View PDFView articleView in Scopus
  • Y. Aso, T. Toshie, T. Tomaru, T. Jojima, I. Usui No negative impact of a national state of emergency by COVID-19 outbreak on hemoglobin A1c levels in patients with type 2 diabetes living in semi-rural Japan Am J Med Sci., 362 (2021), pp. 104-105, 10.1016/j.amjms.2021.03.010 View PDFView articleView in ScopusGoogle Scholar
  • J. Khare, S. Jindal Observational study on effect of lock down due to COVID 19 on HBA1c levels in patients with diabetes: Experience from Central India Prim Care Diabetes. (2021), 10.1016/j.pcd.2020.12.003 S1751-9918(20)30362-4. View PDF Your institution provides access to this article. Google Scholar
  • M.B. Ruiz-Roso, C. Knott-Torcal, D.C. Matilla-Escalante, A. Garcimartín, M.A. Sampedro-Núñez, A. Dávalos, et al. COVID-19 lock-down and changes of the dietary pattern and physical activity habits in a cohort of patients with type 2 diabetes mellitus Nutrients, 4 (2020), p. 2327, 10.3390/nu12082327 View article Google Scholar
  • F.J. Cuevas Fernández, A.A. Pérez de Armas, E. Cerdeña Rodríguez, M. Hernández Andreu, M.J. Iglesias Girón, M.R. García Marrero, et al. Mal control de la diabetes tipo 2 en un centro de salud de AP: factores modificables y población diana Aten Primaria., 53 (2021), p. 102066, 10.1016/j.aprim.2021.10206621 View PDFView articleView in ScopusGoogle Scholar
  • F.J. Cuevas Fernández, J.C. Gutiérrez Galeote, M.R. García Marrero, M.J. Iglesias Girón, A. Cabrera de León, A. Aguirre-Jaina Impacto de la alteración de la continuidad asistencial en los pacientes con diabetes tipo 2 durante la pandemia de COVID-19 Semergen., 48 (2022), pp. 308-315, 10.1016/j.semerg.2022.02.007 View PDFView articleView in ScopusGoogle Scholar
  • M.J. Crowley, P.E. Tarkington, H.B. Bosworth, A.S. Jeffreys, C.J. Coffman, M.L. Maciejewski, et al. Effect of a comprehensive telehealth intervention vs. telemonitoring and care coordination in patients with persistently poor type 2 diabetes control: A randomized clinical trial JAMA Intern Med., 182 (2022), pp. 943-952, 10.1001/jamainternmed.2022.2947 View PDF This article is free to access. View in ScopusGoogle Scholar
Data source: Dialnet